Τίτλος:
Antipsychotic Treatment of 22q112 Deletion Syndrome-Related Psychoses
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
In the recent study by Verhoeven and Egger, 2015 and the recent letter to the editor by Boot et al. 2015 an emphasis is given to the best possible pharmacological treatment of 22q11-2 Deletion-Syndrome related psychoses. We would like to present the case of a 23-year old Cypriot patient with 22q11.2 deletion syndrome who fulfilled criteria for treatment resistant schizophrenia (TRS). He was sequentially treated with aripiprazole, risperidone, olanzapine, haloperidol and a combination treatment with olanzapine and haloperidol. Clozapine was the only antipsychotic medication that has improved his condition. © Georg Thieme Verlag KG Stuttgart, New York.
Συγγραφείς:
Angelopoulos, E.
Theleritis, C.
Economou, M.
Georgatou, K.
Papageorgiou, C.C.
Tsaltas, E.
Περιοδικό:
INTERNATIONAL PHARMACOPSYCHIATRY
Εκδότης:
Georg Thieme Verlag
Λέξεις-κλειδιά:
aripiprazole; brain derived neurotrophic factor; CD4 antigen; CD8 antigen; clonazepam; clozapine; complement component C3; complement component C4; cytochrome P450 1A2; cytochrome P450 2C9; cytochrome P450 3A5; fluvoxamine; glutamic acid; haloperidol; hydroxyproline; immunoglobulin A; immunoglobulin G; immunoglobulin M; neuroleptic agent; olanzapine; risperidone; topiramate; triacylglycerol; unclassified drug; viperiden; clozapine; neuroleptic agent, 22q11.2 deletion syndrome; add on therapy; aggression; agitation; amino acid analysis; amnesia; anxiety; Article; auditory hallucination; biochemistry; case report; chromosome deletion; Clinical Global Impression scale; cognitive behavioral therapy; computer assisted tomography; Cypriot; depression; drug withdrawal; dystonia; echocardiography; electrocardiography; electroencephalography; ENT examination; extrapyramidal symptom; Fahr disease; fluorescence in situ hybridization; genetic analysis; genotype; Global Assessment of Functioning; hearing impairment; hospitalization; human; mental deficiency; mini international neuropsychiatric interview; nuclear magnetic resonance imaging; persecutory delusion; priority journal; psychosocial rehabilitation; psychosocial withdrawal; quality of life; social competence; Structured Clinical Interview for DSM Disorders; trail making test; treatment duration; treatment-resistant schizophrenia; Wechsler adult intelligence scale; Wisconsin Card Sorting Test; complication; DiGeorge syndrome; drug effects; drug resistance; male; psychology; psychosis; young adult, Antipsychotic Agents; Clozapine; DiGeorge Syndrome; Drug Resistance; Humans; Male; Psychotic Disorders; Young Adult
DOI:
10.1055/s-0043-109559
